Acquisitions and Dispositions (Tables)

12 Months Ended

Dec. 31, 2012

Acquisitions and Dispositions Disclosure

Schedule of Purchase Price Allocation [Table Text Block]

       The components of the purchase price and net assets acquired for 2012 acquisitions are as follows:

(In millions)			One Lambda		Doe & Ingalls		Other		Total
Purchase Price
	Cash paid		$	878.8	$	174.8	$	25.4	$	1,079.0
	Purchase price payable			7.3		—		—		7.3
	Fair value of contingent consideration			13.1		1.5		5.3		19.9
	Cash acquired			(1.3)		—		—		(1.3)
			$	897.9	$	176.3	$	30.7	$	1,104.9
Net Assets Acquired
	Current assets		$	110.1	$	21.9	$	2.2	$	134.2
	Property, plant and equipment			30.3		11.6		0.1		42.0
	Intangible assets:
		Customer relationships		330.7		68.1		3.2		402.0
		Product technology		172.5		1.1		13.9		187.5
		Tradenames and other		17.2		16.8		—		34.0
	Goodwill			273.5		81.1		15.6		370.2
	Other assets			—		0.5		—		0.5
	Liabilities assumed			(36.4)		(24.8)		(4.3)		(65.5)
			$	897.9	$	176.3	$	30.7	$	1,104.9

The components of the purchase price and net assets acquired for 2011 acquisitions, as revised in 2012 for finalization of the valuation process are as follows:

(In millions)			Phadia		Dionex		Other		Total
Purchase Price
	Cash paid		$	3,655.2	$	2,140.8	$	97.7	$	5,893.7
	Debt assumed			0.3		3.2		—		3.5
	Purchase price payable			—		—		0.4		0.4
	Fair value of contingent consideration			—		—		1.4		1.4
	Cash acquired			(117.2)		(114.9)		(0.9)		(233.0)
			$	3,538.3	$	2,029.1	$	98.6	$	5,666.0
Net Assets Acquired
	Current assets		$	328.1	$	227.8	$	25.0	$	580.9
	Property, plant and equipment			150.2		87.8		29.0		267.0
	Intangible assets:
		Customer relationships		956.8		495.3		17.6		1,469.7
		Product technology		696.3		350.2		20.0		1,066.5
		In-process research and development		—		18.3		—		18.3
		Tradenames and other		132.6		35.7		3.6		171.9
	Goodwill			1,813.6		1,317.8		30.2		3,161.6
	Other assets			67.9		3.1		1.2		72.2
	Liabilities assumed			(607.2)		(506.9)		(28.0)		(1,142.1)
			$	3,538.3	$	2,029.1	$	98.6	$	5,666.0

       The components of the purchase price and net assets acquired for 2010 acquisitions, as revised in 2011 for finalization of the valuation process are as follows:

(In millions)			Ahura Scientific		Finnzymes		Fermentas		Other		Total
Purchase Price
	Cash paid		$	164.0	$	59.0	$	278.7	$	150.6	$	652.3
	Debt assumed			0.6		—		3.6		1.1		5.3
	Fair value of contingent consideration			19.6		—		—		3.9		23.5
	Cash acquired			(17.8)		(0.7)		(21.9)		(5.4)		(45.8)
			$	166.4	$	58.3	$	260.4	$	150.2	$	635.3
Net Assets Acquired
	Current assets		$	22.3	$	6.1	$	23.3	$	29.4	$	81.1
	Property, plant and equipment			3.3		3.4		9.6		4.1		20.4
	Intangible assets:
		Customer relationships		46.1		16.1		67.9		40.6		170.7
		Product technology		30.4		18.6		73.5		24.8		147.3
		In-process research and development		—		—		—		4.4		4.4
		Tradenames and other		0.4		0.1		5.3		4.4		10.2
	Goodwill			109.9		24.8		117.2		62.5		314.4
	Other assets			0.1		2.0		3.0		9.0		14.1
	Liabilities assumed			(46.1)		(12.8)		(39.4)		(29.0)		(127.3)
			$	166.4	$	58.3	$	260.4	$	150.2	$	635.3

Business Acquisition, Pro Forma Information [Table Text Block]

Unaudited Pro Forma Information

The company acquired Dionex Corporation in May 2011, the Phadia group in August 2011 and One Lambda in September 2012. Had the acquisitions of Dionex and Phadia been completed as of the beginning of 2010, and the acquisition of One Lambda been completed as of the beginning of 2011, the company's pro forma results for 2012 and 2011 would have been as follows:

(In millions except per share amounts)		2012		2011
Revenues		$	12,643.0	$	12,292.1
Income from Continuing Operations		$	1,338.5	$	1,133.9
Net Income		$	1,258.0	$	1,440.3
Earnings per Share from Continuing Operations:
	Basic	$	3.68	$	2.98
	Diluted	$	3.65	$	2.95
Earnings per Share:
	Basic	$	3.46	$	3.78
	Diluted	$	3.43	$	3.74